Evidence map›Paper›PMID 31552143›Full record

ArticleCell death discovery2019

Soluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic mice.

Prerak M Trivedi, Stacey Fynch, Lucy M Kennedy, Jonathan Chee, Balasubramanian Krishnamurthy, Lorraine A O'Reilly, Andreas Strasser, Thomas W H Kay, Helen E Thomas

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Pathogenesis and advances in immunotherapy for type 1 diabetes treatment.Biotechnology reports (Amsterdam, Netherlands) · 2026
    Review
  2. Article
  3. Bioactive Compounds inPlants (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Journal of traditional and complementary medicine · 2023
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Prerak M Trivedi1St. Vincent's Institute, Fitzroy, Victoria 3065 Australia.
Stacey Fynch1St. Vincent's Institute, Fitzroy, Victoria 3065 Australia.
Lucy M Kennedy1St. Vincent's Institute, Fitzroy, Victoria 3065 Australia.
Jonathan Chee1St. Vincent's Institute, Fitzroy, Victoria 3065 Australia.ORCID 0000-0002-7986-2708
Balasubramanian Krishnamurthy1St. Vincent's Institute, Fitzroy, Victoria 3065 Australia.
Lorraine A O'Reilly3The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050 Australia.
Andreas Strasser3The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050 Australia.
Thomas W H Kay1St. Vincent's Institute, Fitzroy, Victoria 3065 Australia.
Helen E Thomas1St. Vincent's Institute, Fitzroy, Victoria 3065 Australia.
St Vincents Institute of Medical Research · AUThe University of Melbourne · AUMemorial Sloan Kettering Cancer Center · USThe University of Western Australia · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD8

Indexed as

AutoimmunityType 1 diabetes

Identifiers

PMID31552143
PMCPMC6755132
OpenAlexW2973311822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.